Navigation Links
NIAID strengthens and expands Vaccine and Treatment Evaluation Units
Date:11/6/2007

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded eight contracts to strengthen and expand its nationwide group of institutions conducting clinical trials of promising candidate vaccines and therapies for infectious diseases. In addition to increasing the number of sites from seven to eight, NIAID expects the Vaccine and Treatment Evaluation Units (VTEUs) to carry out more clinical trials in larger populations and to safely test vaccines in specific vulnerable populations, such as infants and the elderly. Moreover, all the VTEUs will have inpatient beds for isolating volunteers who participate in the testing of vaccines containing weakened versions of live microbes, making it easier to conduct such trials quickly.

Each VTEU will receive approximately $23.7 million over seven years. The combined capabilities of these research facilitieslocated in Atlanta, Baltimore, Cincinnati, Houston, Iowa City, Nashville, Seattle and St. Louiswill enhance NIAIDs ability to direct clinical research to quickly respond to emerging public health needs.

In more than four decades of research, the VTEUs have conducted hundreds of clinical trials of investigational vaccines and therapeutics for a variety of infectious diseases of public health concern, and many of these trials have contributed to the licensure of products, says NIAID Director Anthony S. Fauci, M.D. We expect this success to continue, as each VTEU has exceptional expertise and experience in vaccinology and an impressive capacity to recruit volunteers from diverse populations in its community.

Established in 1962, the VTEUs are a national resource for vaccine development. VTEU investigators have tested and advanced vaccines for many diseases, including influenza, pneumonia, whooping cough, Haemophilus influenzae infection, cytomegalovirus infection, malaria, smallpox, anthrax and tularemia. Childhood vaccines and combi
'/>"/>

Contact: Laura Sivitz
sivitzl@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. NIAID funds $51M contract to create comprehensive model of immune responses
2. Kenyan malaria success strengthens call for free insecticide-treated nets for all
3. International study strengthens case for daily calcium pill
4. Wachovia Strengthens Its Healthcare Industry Receivables and Cash Management Capabilities
5. Essilor Strengthens its Polarized Lens Distribution Network With the Acquisition of KBco
6. Publicis Groupe Strengthens its Leadership in Digital and Integrated Healthcare Communications in Italy
7. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
8. Rohm and Haas Expands in India
9. Concentra Expands Horizon Air Employee Health Program With On-Site Clinic
10. Regional Center of Orange County Expands Family Support Resources to Meet Growing Needs
11. Maimonides Expands Circulation of Physicians Practice Journal to Staten Island Doctors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...1 Today, prescription dr...in treating 88 percent of patients suffering chron...d for a chronic condition account for 96 percent o... all medical costs. A proprietary new pharmacy mo...utions, Inc. (NYSE: MHS ) significantly reduces ...
(Date:11/21/2008)... -- In a statewide survey, 33 physicians credentia... at Presbyterian Hospital of Dallas were honored b...Super Doctors ." , , Each year, the publish...Media, Inc. to survey more than 38,000 medical pro...ou needed medical care, which doctor would you cho...
(Date:11/21/2008)...is more prevalent and smoking cessation less likel...ty Disorder (A.D.H.D.) In a study of smokers with...se who exhibited elevated hyperactivity and impuls...uit rates after 8 weeks than those with inattentio...ptoms. The study, now available online in Nicoti...
(Date:11/21/2008)...ire/ -- New inventions in computerized brain,trai...isabilities lead fuller,lives, said Jeff Zimman, ...presented today at the annual Technology Innovator...ed by The National Center for Technology Innovatio...abilities. , Zimman said cognitive training...
Breaking Medicine News(10 mins):Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6Health News:Annual List of 'Super Doctors' Features 33 Texas Institute for Surgery Physicians 2Health News:Ability to quit smoking may depend on ADHD symptoms, Columbia researchers find 2Health News:New Applications for Cognitive Training 2
...is awaited from the Italian court, presiding over ...rgio Welby - suffering// from muscular dystrophy, ...the court to allow the doctors to disengage him fr...e. Italy, largely influenced by Roman Catholic se...
...in two Bihar villages soon after being administere...n Saturday. About 100 kids were reportedly ill// a...the deaths took place in Khaira and Sahar villages... 60 km from here. Twelve children have been admitt...
... being considered as a plausible culprit for rende...y returned home from school. The dynamic stomach ...nts in the John F. Ryan Elementary School, and was...parents and siblings alike! “The school has just ...
... news in the air. To tackle obesity in school chil... young, a proposal to include yoga in the// school...e green signal from the HRD ministry. While annou...inister A Ramadoss said,"Yoga can go a long way in...
Other Medicine News:
(Date:11/19/2008)... , Study did not achieve statistical significan...irstCall/ -- Pharmos Corporation (Nasdaq: PARS )...l trial of its topical NanoEmulsion (NE) drug deli...hanolamine. , , The multi-center, randomize...ted the safety and efficacy of the Company,s 3% Di...
(Date:11/19/2008)..., Del., Nov. 19 Isogen, a contract...terile filling, today announced the first,phase l... was founded to,specifically address the process,...ed with the $2 billion highly-niched, low-volume c...g market segment. , Companies can invest ov...
(Date:11/18/2008)... www.christmasseals.org to learn more, make a don...WASHINGTON, Nov. 17 Mil...s month, courtesy of the American Lung Association...nnual fundraising tradition dating back to 1907 wh...erculosis. , , "Most Americans alive toda...
(Date:11/18/2008)...an Lung Association,s 2008 Faces of Influenza surv...mmunized against influenza; Mother and Gold Medali...ASHINGTON, Nov. 18 While 78 percen...za a severe and potentially life-threatening disea...ely their families will get vaccinated this season...
Breaking Medicine Technology:Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Isogen Launches Major New Facility to Address Global Biopharma Demand 2American Lung Association Celebrates 101st Annual Christmas Seals Campaign 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 4Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 5Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 6Harvard Researchers Select S C BlueCross for National Honor 873 1Harvard Researchers Select S C BlueCross for National Honor 873 2Harvard Researchers Select S C BlueCross for National Honor 873 3Purdue Pharma Selects Systech to Provide Sustainable Infrastructure for Serialization 868 1Purdue Pharma Selects Systech to Provide Sustainable Infrastructure for Serialization 868 2Kiwa Bio Tech Named Recommended Brand by the China Green Food Association 463 1Kiwa Bio Tech Named Recommended Brand by the China Green Food Association 463 2SinuNase Phase 3 show almost 100 percent of chronic sinusitis cases are from fungal induced inflamma 318 1SinuNase Phase 3 show almost 100 percent of chronic sinusitis cases are from fungal induced inflamma 318 2
...March 6, 2007-Pozen Inc. (NASDAQ: POZN),today ann...325,proof-of-concept study conducted during the fo...tion of 325mg of aspirin surrounded by,a 20mg coat...n pump,inhibitor. , The PA 325, 28 day study, invo... Each subject was treated with either once a day,c...
...SINESS WIRE)--Mar 5, 2007 - Advanced Cell,Technolo...in blind,rats was noted in Scientific American,s M... section. The full text of the article,which note...cells,to turn into transplantable retinal pigment ...ortly after the company announced,its collaboratio...
Other Medicine Technology:Pozen Announces Positive Outcome for PA 325 2Pozen Announces Positive Outcome for PA 325 3Advanced Cell Technology's Ability to Rescue Vision in Blind Rats,Noted in Scientific American 2Advanced Cell Technology's Ability to Rescue Vision in Blind Rats,Noted in Scientific American 3
The Doro Halo retractor system is designed for all neurosurgical applications where retraction of the brain tissue and an armrest is required.
Molt 9, excellent for subperiosteal tunneling.
Love-Adson periosteal elevator, semi sharp, blade width 3/16" (5 mm), length 6 1/2" (165 mm).
Iowa University periosteal elevator, blade width 11/16" (17 mm), length 7 1/4" (184 mm).
Medicine Products: